Abstract
The COVID-19 pandemic caused by the SARS-CoV-2 virus has affected millions of people around the globe. The most common presentation of COVID-19 is fever and upper and lower respiratory tract infection. Myalgia is fairly common in the prodromal phase of the viral illness which self-resolves. There is very scant literature on autoimmune myositis triggered by COVID-19 infection. We report a case of SARS-CoV-2 infection, who presented with progressive muscle weakness with rhabdomyolysis and necrotizing autoimmune myopathy on muscle biopsy. This case report imposes awareness of musculoskeletal autoimmune processes triggered by COVID-19 which requires clinical suspicion for early diagnosis and initiation of treatment.
Keywords: infections; muscle disease; musculoskeletal and joint disorders; neurology (drugs and medicines).
【저자키워드】 infections, muscle disease, musculoskeletal and joint disorders, neurology (drugs and medicines), 【초록키워드】 COVID-19, SARS-COV-2 infection, COVID-19 pandemic, Infection, Case report, early diagnosis, COVID-19 infection, Fever, Autoimmune, Lower respiratory tract, Medicines, Musculoskeletal, clinical suspicion, weakness, joint, affected, caused, globe, triggered, initiation of treatment, the SARS-CoV-2 virus, 【제목키워드】 COVID-19, Autoimmune, Inflammatory,